Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she has taken to ensure the Medicines and Healthcare products Regulatory Agency is adequately resourced.
Funding for the Medicines and Healthcare products Regulatory Agency (MHRA) is determined in advance through collaborative Spending Review processes. This funding has been provided for the MHRA’s transformation programme to ensure an efficient organisation, which focuses on patient safety and engagement and improving access to innovation in the National Health Service. It is currently consulting on increases to its statutory fees to ensure all costs involved are recovered.